Wave Life Sciences (WVE) Treasury Shares (2015 - 2026)
Wave Life Sciences (WVE) posted Treasury Shares of $3.2 million for Q1 2026, down 16.87% on a QoQ basis from $3.9 million in Q4 2025, and down 16.87% year-over-year from $3.9 million in Q1 2025.
Wave Life Sciences (WVE) Treasury Shares (2015 - 2026) Analysis & Trends
Wave Life Sciences' Treasury Shares history runs 12 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- Quarterly Treasury Shares fell 16.87% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 16.87% YoY) and the FY2025 annual result came in at $3.9 million, changed 0.0% from the prior year.
- Treasury Shares was $3.2 million for Q1 2026 at Wave Life Sciences, down from $3.9 million in the prior quarter.
- Across five years, Treasury Shares topped out at $3.9 million in Q1 2022 and bottomed at $3.2 million in Q1 2026.
- A 5-year average of $3.9 million and a median of $3.9 million in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares changed 0.0% — and 2026, when it retreated 16.87%.
- Wave Life Sciences' Treasury Shares stood at $3.9 million in 2022, then changed by 0.0% to $3.9 million in 2023, then changed by 0.0% to $3.9 million in 2024, then changed by 0.0% to $3.9 million in 2025, then slipped by 16.87% to $3.2 million in 2026.
- Business Quant data shows WVE's Treasury Shares at $3.2 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Wave Life Sciences | 1.16 Bn | 612.38 Mn | - | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.24 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 3.90 Mn |
| Dec 31, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Sep 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Dec 31, 2023 | 3.90 Mn |